-Prostrakan Receives Fda Approval for Abstral in Us

Summary


EQUITYBITES-(C)2011 M2 COMMUNICATIONS

Pharmaceutical company Orexo AB (STO:ORX.st) announced today that its partner ProStrakan Group plc (LSE:PSK.l), a specialty pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for Abstral.

See the full content of this document

Extract


-Prostrakan Receives Fda Approval for Abstral in Us

Abstral is licensed for the treatment of breakth...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company